{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:12:05Z","timestamp":1767211925321},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T00:00:00Z","timestamp":1361404800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1002899","type":"journal-article","created":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T23:36:12Z","timestamp":1361489772000},"page":"e1002899","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":44,"title":["Significantly Improved HIV Inhibitor Efficacy Prediction Employing Proteochemometric Models Generated From Antivirogram Data"],"prefix":"10.1371","volume":"9","author":[{"given":"Gerard J. P.","family":"van Westen","sequence":"first","affiliation":[]},{"given":"Alwin","family":"Hendriks","sequence":"additional","affiliation":[]},{"given":"J\u00f6rg K.","family":"Wegner","sequence":"additional","affiliation":[]},{"given":"Adriaan P.","family":"IJzerman","sequence":"additional","affiliation":[]},{"given":"Herman W. T.","family":"van Vlijmen","sequence":"additional","affiliation":[]},{"given":"Andreas","family":"Bender","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2013,2,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.6189183","article-title":"Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)","volume":"220","author":"F Barre-Sinoussi","year":"1983","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.6200935","article-title":"Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS","volume":"224","author":"M Popovic","year":"1984","journal-title":"Science"},{"key":"ref3","unstructured":"UNAIDS (2011) Progress Report: Global HIV\/AIDS Response. Geneva, Switserland: UNAIDS."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(98)24010-4","article-title":"CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort Study","volume":"351","author":"D Kaufmann","year":"1998","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection","volume":"338","author":"FJ Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"ref6","first-page":"156","article-title":"2011 update of the drug resistance mutations in HIV-1","volume":"19","author":"VA Johnson","year":"2011","journal-title":"Top Antivir Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.2460924","article-title":"Fidelity of HIV-1 reverse transcriptase","volume":"242","author":"B Preston","year":"1988","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1126\/science.2460925","article-title":"The accuracy of reverse transcriptase from HIV-1","volume":"242","author":"J Roberts","year":"1988","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/00002030-200006160-00018","article-title":"Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples","volume":"14","author":"K Hertogs","year":"2000","journal-title":"AIDS"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/jama.283.3.381","article-title":"Antiretroviral Therapy in Adults","volume":"283","author":"CCJ Carpenter","year":"2000","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.280.5371.1871","article-title":"HIV Treatment Failure: Testing for HIV Resistance in Clinical Practice","volume":"280","author":"L Perrin","year":"1998","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/AAC.42.2.269","article-title":"A Rapid Method for Simultaneous Detection of Phenotypic Resistance to Inhibitors of Protease and Reverse Transcriptase in Recombinant Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Antiretroviral Drugs","volume":"42","author":"K Hertogs","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1128\/AAC.44.4.920-928.2000","article-title":"A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1","volume":"44","author":"CJ Petropoulos","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1386-6532(99)00010-4","article-title":"Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors","volume":"13","author":"H Walter","year":"1999","journal-title":"J Clin Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/135965350200700206","article-title":"A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients","volume":"7","author":"K Van Laethem","year":"2002","journal-title":"Antivir Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1086\/375355","article-title":"Variable Prediction of Antiretroviral Treatment Outcome by Different Systems for Interpreting Genotypic Human Immunodeficiency Virus Type 1 Drug Resistance","volume":"187","author":"A De Luca","year":"2003","journal-title":"J Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00002030-200203290-00008","article-title":"Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial","volume":"16","author":"J-L Meynard","year":"2002","journal-title":"AIDS"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1086\/505356","article-title":"Rationale and Uses of a Public HIV Drug-Resistance Database","volume":"194","author":"W Shafer Robert","year":"2006","journal-title":"J Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1086\/597305","article-title":"Predicting the Response to Combination Antiretroviral Therapy: Retrospective Validation of geno2pheno-THEO on a Large Clinical Database","volume":"199","author":"A Altmann","year":"2009","journal-title":"J Infect Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1093\/nar\/gkg575","article-title":"Geno2pheno: Estimating phenotypic drug resistance from HIV-1 genotypes","volume":"31","author":"N Beerenwinkel","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/135965350300800604","article-title":"Phenotype or virtual phenotype for choosing antiretroviral therapy after failure: a prospective, randomized study","volume":"8","author":"MJ Perez-Elias","year":"2003","journal-title":"Antivir Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/313277a0","article-title":"Complete nucleotide sequence of the AIDS virus, HTLV-III","volume":"313","author":"L Ratner","year":"1985","journal-title":"Nature"},{"key":"ref23","unstructured":"Korber BT, Foley BT, Kuiken CL, Pillai SK, Sodroski JG (1998) Numbering Positions in HIV Relative to HXB2CG. Los Alamos: Los Alamos National Laboratory."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/JVI.59.2.284-291.1986","article-title":"Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone","volume":"59","author":"A Adachi","year":"1986","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jviromet.2007.05.009","article-title":"Prediction of HIV-1 drug susceptibility phenotype from the viral genotype using linear regression modeling","volume":"145","author":"H Vermeiren","year":"2007","journal-title":"J Virol Methods"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/sim.1516","article-title":"Non-parametric methods to predict HIV drug susceptibility phenotype from genotype","volume":"22","author":"A DiRienzo","year":"2003","journal-title":"Stat Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/bioinformatics\/btr515","article-title":"HIV Therapy Simulator: a graphical user interface for comparing the effectiveness of novel therapy regimens","volume":"27","author":"HC Lim","year":"2011","journal-title":"Bioinformatics"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"i16","DOI":"10.1093\/bioinformatics\/btg1001","article-title":"Methods for optimizing antiviral combination therapies","volume":"19","author":"N Beerenwinkel","year":"2003","journal-title":"Bioinformatics"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1039\/b409813g","article-title":"Molecular similarity: a key technique in molecular informatics","volume":"2","author":"A Bender","year":"2004","journal-title":"Org Biomol Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1471-2105-9-181","article-title":"Proteochemometric modeling of HIV protease susceptibility","volume":"9","author":"M Lapins","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1016\/j.bmc.2009.05.045","article-title":"Proteochemometrics mapping of the interaction space for retroviral proteases and their substrates","volume":"17","author":"A Kontijevskis","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1039\/C0MD00165A","article-title":"Proteochemometric Modeling as a Tool for Designing Selective Compounds and Extrapolating to Novel Targets","volume":"2","author":"GJP Van Westen","year":"2011","journal-title":"MedChemComm"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e27518","DOI":"10.1371\/journal.pone.0027518","article-title":"Which Compound to Select in Lead Optimization? Prospectively Validated Proteochemometric Models Guide Preclinical Development","volume":"6","author":"GJP Van Westen","year":"2011","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1021\/ci800453k","article-title":"Proteochemometric Modeling of Drug Resistance over the Mutational Space for Multiple HIV Protease Variants and Multiple Protease Inhibitors","volume":"49","author":"M Lapins","year":"2009","journal-title":"J Chem Inf Model"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e14353","DOI":"10.1371\/journal.pone.0014353","article-title":"Proteochemometric Modeling of the Susceptibility of Mutated Variants of the HIV-1 Virus to Reverse Transcriptase Inhibitors","volume":"5","author":"M Junaid","year":"2010","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Tropsha A (2010) Predictive Quantitative Structure-Activity Relationships Modeling. In: Faulon J, Bender A, editors. Handbook of Chemoinformatics Algorithms.","DOI":"10.1201\/9781420082999-c6"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.2174\/138161207782794257","article-title":"Predictive QSAR Modeling Workflow, Model Applicability Domains, and Virtual Screening","volume":"13","author":"A Tropsha","year":"2007","journal-title":"Curr Pharm Des"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1021\/jm960290n","article-title":"Neighborhood Behavior: A Useful Concept for Validation of \u201cMolecular Diversity\u201d Descriptors","volume":"39","author":"DE Patterson","year":"1996","journal-title":"J Med Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/1471-2105-12-386","article-title":"Cross-validated stepwise regression for identification of novel non-nucleoside reverse transcriptase inhibitor resistance associated mutations","volume":"12","author":"K Van der Borght","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"ref40","first-page":"125","article-title":"Update of the drug resistance mutations in HIV-1: Fall 2006","volume":"14","author":"V Johnson","year":"2006","journal-title":"Top HIV Med"},{"key":"ref41","first-page":"A26","article-title":"An update of the list of NNRTI mutations associated with decreased virological response to etravirine: multivariate analysis on the pooled DUET-1 and DUET-2 clinical trial data [abstract 24]","volume":"13: Suppl 3","author":"J Vingerhoets","year":"2008","journal-title":"Antivir Ther"},{"key":"ref42","first-page":"67","article-title":"HIV-1 drug resistance mutations: an updated framework for the second decade of HAART","volume":"10","author":"RW Shafer","year":"2008","journal-title":"AIDS Rev"},{"key":"ref43","first-page":"179","article-title":"Novel drug resistance mutations in HIV: recognition and clinical relevance","volume":"8","author":"CF Perno","year":"2006","journal-title":"AIDS Rev"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"17355","DOI":"10.1073\/pnas.0607274103","article-title":"Genotypic predictors of human immunodeficiency virus type 1 drug resistance","volume":"103","author":"S-Y Rhee","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/364679b0","article-title":"HIV and multidrug resistance","volume":"364","author":"EA Emini","year":"1993","journal-title":"Nature"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.1073\/pnas.90.12.5653","article-title":"Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3\u2032-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase","volume":"90","author":"M Tisdale","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1128\/AAC.38.6.1404","article-title":"Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitors","volume":"38","author":"VW Byrnes","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1128\/JVI.74.2.1023-1028.2000","article-title":"High-Level Resistance to 3\u2032-Azido-3\u2032-Deoxythimidine due to a Deletion in the Reverse Transcriptase Gene of Human Immunodeficiency Virus Type 1","volume":"74","author":"T Imamichi","year":"2000","journal-title":"J Virol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1128\/AAC.48.12.4611-4617.2004","article-title":"Gln145Met\/Leu Changes in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Resistance to Nucleoside and Nonnucleoside Analogs and Impair Virus Replication","volume":"48","author":"S Paolucci","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1086\/430706","article-title":"Accuracy, Precision, and Consistency of Expert HIV Type 1 Genotype Interpretation: An International Comparison (The GUESS Study)","volume":"41","author":"AR Zolopa","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/jmv.21585","article-title":"A comparison of HIV-1 drug susceptibility as provided by conventional phenotyping and by a phenotype prediction tool based on viral genotype","volume":"81","author":"M Van Houtte","year":"2009","journal-title":"J Med Virol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1021\/jm9700575","article-title":"New Chemical Descriptors Relevant for the Design of Biologically Active Peptides. A Multivariate Characterization of 87 Amino Acids","volume":"41","author":"M Sandberg","year":"1998","journal-title":"J Med Chem"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1021\/jm00390a003","article-title":"Peptide quantitative structure-activity relationships, a multivariate approach","volume":"30","author":"S Hellberg","year":"1987","journal-title":"J Med Chem"},{"key":"ref54","first-page":"199","article-title":"Circular fingerprints: Flexible molecular descriptors with applications from physical chemistry to ADME","volume":"9","author":"RC Glen","year":"2006","journal-title":"IDrugs"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1021\/ci100050t","article-title":"Extended-Connectivity Fingerprints","volume":"50","author":"D Rogers","year":"2010","journal-title":"J Chem Inf Model"},{"key":"ref56","unstructured":"Accelrys Software Inc Pipeline Pilot Student Edition. Version 6.1.5 ed: Scitegic."},{"key":"ref57","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1021\/ci800249s","article-title":"How Similar Are Similarity Searching Methods? A Principal Component Analysis of Molecular Descriptor Space","volume":"49","author":"A Bender","year":"2009","journal-title":"J Chem Inf Model"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1021\/ci9800211","article-title":"Chemical Similarity Searching","volume":"38","author":"P Willett","year":"1998","journal-title":"J Chem Inf Comput Sci"},{"key":"ref59","unstructured":"R Development Core Team (2006) R: A Language and Environment for Statistical Computing."},{"key":"ref60","unstructured":"Dimitriadou E, Hornik K, Leisch F, Meyer D, Weingessel A (2006) Misc Functions of the Department of Statistics (e1071). 1.5-15 ed. Wien: TU Wien."},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Vapnik V (1995) The Nature of Statistical Learning. New York: Springer.","DOI":"10.1007\/978-1-4757-2440-0"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1093-3263(01)00123-1","article-title":"Beware of q2!","volume":"20","author":"A Golbraikh","year":"2002","journal-title":"J Mol Graph Model"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1128\/JCM.42.5.2353-2354.2004","article-title":"Weak Agreement between Antivirogram and PhenoSense Assays in Predicting Reduced Susceptibility to Antiretroviral Drugs","volume":"42","author":"K Wang","year":"2004","journal-title":"J Clin Microbiol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/135965350400900501","article-title":"Antivirogram or phenosense: a comparison of their reproducibility and an analysis of their correlation","volume":"9","author":"K Wang","year":"2004","journal-title":"Antivir Ther"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/01.qai.0000147526.64863.53","article-title":"Comparison of the Precision and Sensitivity of the Antivirogram and PhenoSense HIV Drug Susceptibility Assays","volume":"38","author":"J Zhang","year":"2005","journal-title":"JAIDS J Acquir Immune Defic Syndr"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002899","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T18:15:52Z","timestamp":1688062552000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002899"}},"subtitle":[],"editor":[{"given":"Sergei L.","family":"Kosakovsky Pond","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2013,2,21]]},"references-count":65,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1002899","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,21]]}}}